Canadian licensed producer Aurora Cannabis has completed its first shipment of medical cannabis products to the Czech Republic, MarketWatch reports.
The Czech Republic is the 21st country to have its medical cannabis needs met by Aurora Cannabis. The Czech Republic started its medical cannabis program in 2013. Patients in the country are allowed 180 grams of dry flower a month, which must be prescribed by an approved doctor.
“This supply arrangement demonstrates our ability to enter into new jurisdictions as the partner of choice in new markets with strong barriers to entry, and is testament to the strength and business execution of our European business development team.” — Neil Belot, Chief Global Business Development Officer for Aurora Cannabis, in a press release
Aurora Cannabis is one of the largest producers of cannabis in Canada. The company was recently approved to list on the New York Stock Exchange, making them only the third cannabis company to trade publicly in the U.S.
Despite an influx of good news stories for Aurora — including the Czech delivery — the company’s share prices continue to fall. Most other publicly-traded cannabis companies are seeing the same, having previously enjoyed a boom from investor speculation on the newly-legalized industry, but initial excitement for the industry is starting to wear off.